202 related articles for article (PubMed ID: 29378236)
1. Partial growth hormone insensitivity and dysregulatory immune disease associated with de novo germline activating STAT3 mutations.
Gutiérrez M; Scaglia P; Keselman A; Martucci L; Karabatas L; Domené S; Martin A; Pennisi P; Blanco M; Sanguineti N; Bezrodnik L; Di Giovanni D; Caldirola MS; Azcoiti ME; Gaillard MI; Denson LA; Zhang K; Husami A; Yayah Jones NH; Hwa V; Revale S; Vázquez M; Jasper H; Kumar A; Domené H
Mol Cell Endocrinol; 2018 Sep; 473():166-177. PubMed ID: 29378236
[TBL] [Abstract][Full Text] [Related]
2. Short Stature in a Boy with Multiple Early-Onset Autoimmune Conditions due to a STAT3 Activating Mutation: Could Intracellular Growth Hormone Signalling Be Compromised?
.
Sediva H; Dusatkova P; Kanderova V; Obermannova B; Kayserova J; Sramkova L; Zemkova D; Elblova L; Svaton M; Zachova R; Kolouskova S; Fronkova E; Sumnik Z; Sediva A; Lebl J; Pruhova S
Horm Res Paediatr; 2017; 88(2):160-166. PubMed ID: 28253502
[TBL] [Abstract][Full Text] [Related]
3. STAT5B deficiency: Impacts on human growth and immunity.
Hwa V
Growth Horm IGF Res; 2016 Jun; 28():16-20. PubMed ID: 26703237
[TBL] [Abstract][Full Text] [Related]
4. Activating mutations of STAT3: Impact on human growth.
Gutiérrez M
Mol Cell Endocrinol; 2020 Dec; 518():110979. PubMed ID: 32818584
[TBL] [Abstract][Full Text] [Related]
5. Primary growth hormone (GH) insensitivity and insulin-like growth factor deficiency caused by novel compound heterozygous mutations of the GH receptor gene: genetic and functional studies of simple and compound heterozygous states.
Fang P; Riedl S; Amselem S; Pratt KL; Little BM; Haeusler G; Hwa V; Frisch H; Rosenfeld RG
J Clin Endocrinol Metab; 2007 Jun; 92(6):2223-31. PubMed ID: 17405847
[TBL] [Abstract][Full Text] [Related]
6. Clinical and Immunological Heterogeneity in Japanese Patients with Gain-of-Function Variants in STAT3.
Tanita K; Sakura F; Nambu R; Tsumura M; Imanaka Y; Ohnishi H; Kato Z; Pan J; Hoshino A; Suzuki K; Yasutomi M; Umetsu S; Okada C; Takagi M; Imai K; Ohara O; Muise AM; Okada S; Morio T; Kanegane H
J Clin Immunol; 2021 May; 41(4):780-790. PubMed ID: 33501615
[TBL] [Abstract][Full Text] [Related]
7. Genetic analysis of short children with apparent growth hormone insensitivity.
Wit JM; van Duyvenvoorde HA; Scheltinga SA; de Bruin S; Hafkenscheid L; Kant SG; Ruivenkamp CA; Gijsbers AC; van Doorn J; Feigerlova E; Noordam C; Walenkamp MJ; Claahsen-van de Grinten H; Stouthart P; Bonapart IE; Pereira AM; Gosen J; Delemarre-van de Waal HA; Hwa V; Breuning MH; Domené HM; Oostdijk W; Losekoot M
Horm Res Paediatr; 2012; 77(5):320-33. PubMed ID: 22678306
[TBL] [Abstract][Full Text] [Related]
8. A novel missense mutation in the SH2 domain of the STAT5B gene results in a transcriptionally inactive STAT5b associated with severe IGF-I deficiency, immune dysfunction, and lack of pulmonary disease.
Scaglia PA; Martínez AS; Feigerlová E; Bezrodnik L; Gaillard MI; Di Giovanni D; Ballerini MG; Jasper HG; Heinrich JJ; Fang P; Domené HM; Rosenfeld RG; Hwa V
J Clin Endocrinol Metab; 2012 May; 97(5):E830-9. PubMed ID: 22419735
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone and insulin-like growth factor I insensitivity of fibroblasts isolated from a patient with an I{kappa}B{alpha} mutation.
Wu S; Walenkamp MJ; Lankester A; Bidlingmaier M; Wit JM; De Luca F
J Clin Endocrinol Metab; 2010 Mar; 95(3):1220-8. PubMed ID: 20080849
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of STAT proteins on growth hormone-mediated IGF-I gene expression.
Varco-Merth B; Rotwein P
Am J Physiol Endocrinol Metab; 2014 Nov; 307(9):E847-55. PubMed ID: 25205818
[TBL] [Abstract][Full Text] [Related]
11. Phenotypes of STAT3 gain-of-function variant related to disruptive regulation of CXCL8/STAT3, KIT/STAT3, and IL-2/CD25/Treg axes.
Marega LF; Sabino JS; Pedroni MV; Teocchi M; Lanaro C; de Albuquerque DM; Dos Santos IP; Costa FF; Dos Santos Vilela MM
Immunol Res; 2021 Oct; 69(5):445-456. PubMed ID: 34390446
[TBL] [Abstract][Full Text] [Related]
12. Germline STAT3 gain-of-function mutations in primary immunodeficiency: Impact on the cellular and clinical phenotype.
Faletti L; Ehl S; Heeg M
Biomed J; 2021 Aug; 44(4):412-421. PubMed ID: 34366294
[TBL] [Abstract][Full Text] [Related]
13. Genetic disorders of GH action pathway.
Domené HM; Fierro-Carrión G
Growth Horm IGF Res; 2018 Feb; 38():19-23. PubMed ID: 29249625
[TBL] [Abstract][Full Text] [Related]
14. Regulation of IGF-I mRNA and signal transducers and activators of transcription-3 and -5 (Stat-3 and -5) by GH in C2C12 myoblasts.
Frost RA; Nystrom GJ; Lang CH
Endocrinology; 2002 Feb; 143(2):492-503. PubMed ID: 11796503
[TBL] [Abstract][Full Text] [Related]
15. A mutant signal transducer and activator of transcription 5b, associated with growth hormone insensitivity and insulin-like growth factor-I deficiency, cannot function as a signal transducer or transcription factor.
Fang P; Kofoed EM; Little BM; Wang X; Ross RJ; Frank SJ; Hwa V; Rosenfeld RG
J Clin Endocrinol Metab; 2006 Apr; 91(4):1526-34. PubMed ID: 16464942
[TBL] [Abstract][Full Text] [Related]
16. A novel heterozygous STAT5B variant in a patient with short stature and partial growth hormone insensitivity (GHI).
Ramírez L; Sanguineti N; Scaglia P; Keselman A; Ballerini MG; Karabatas L; Landi E; Castro J; Domené S; Pennisi P; Jasper H; Rey RA; Vázquez M; Domené H; Bergadá I; Gutiérrez M
Growth Horm IGF Res; 2020 Feb; 50():61-70. PubMed ID: 31902742
[TBL] [Abstract][Full Text] [Related]
17. Endotoxin attenuates growth hormone-induced hepatic insulin-like growth factor I expression by inhibiting JAK2/STAT5 signal transduction and STAT5b DNA binding.
Chen Y; Sun D; Krishnamurthy VM; Rabkin R
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1856-62. PubMed ID: 17327369
[TBL] [Abstract][Full Text] [Related]
18. Monogenic early-onset lymphoproliferation and autoimmunity: Natural history of STAT3 gain-of-function syndrome.
Leiding JW; Vogel TP; Santarlas VGJ; Mhaskar R; Smith MR; Carisey A; Vargas-Hernández A; Silva-Carmona M; Heeg M; Rensing-Ehl A; Neven B; Hadjadj J; Hambleton S; Ronan Leahy T; Meesilpavikai K; Cunningham-Rundles C; Dutmer CM; Sharapova SO; Taskinen M; Chua I; Hague R; Klemann C; Kostyuchenko L; Morio T; Thatayatikom A; Ozen A; Scherbina A; Bauer CS; Flanagan SE; Gambineri E; Giovannini-Chami L; Heimall J; Sullivan KE; Allenspach E; Romberg N; Deane SG; Prince BT; Rose MJ; Bohnsack J; Mousallem T; Jesudas R; Santos Vilela MMD; O'Sullivan M; Pachlopnik Schmid J; Průhová Š; Klocperk A; Rees M; Su H; Bahna S; Baris S; Bartnikas LM; Chang Berger A; Briggs TA; Brothers S; Bundy V; Chan AY; Chandrakasan S; Christiansen M; Cole T; Cook MC; Desai MM; Fischer U; Fulcher DA; Gallo S; Gauthier A; Gennery AR; Gonçalo Marques J; Gottrand F; Grimbacher B; Grunebaum E; Haapaniemi E; Hämäläinen S; Heiskanen K; Heiskanen-Kosma T; Hoffman HM; Gonzalez-Granado LI; Guerrerio AL; Kainulainen L; Kumar A; Lawrence MG; Levin C; Martelius T; Neth O; Olbrich P; Palma A; Patel NC; Pozos T; Preece K; Lugo Reyes SO; Russell MA; Schejter Y; Seroogy C; Sinclair J; Skevofilax E; Suan D; Suez D; Szabolcs P; Velasco H; Warnatz K; Walkovich K; Worth A; ; Seppänen MRJ; Torgerson TR; Sogkas G; Ehl S; Tangye SG; Cooper MA; Milner JD; Forbes Satter LR
J Allergy Clin Immunol; 2023 Apr; 151(4):1081-1095. PubMed ID: 36228738
[TBL] [Abstract][Full Text] [Related]
19. A novel STAT5B mutation causing GH insensitivity syndrome associated with hyperprolactinemia and immune dysfunction in two male siblings.
Pugliese-Pires PN; Tonelli CA; Dora JM; Silva PC; Czepielewski M; Simoni G; Arnhold IJ; Jorge AA
Eur J Endocrinol; 2010 Aug; 163(2):349-55. PubMed ID: 20538865
[TBL] [Abstract][Full Text] [Related]
20. Past, Present, and Future in the Relationship between Growth Retardation and the IGF System: Excerpts from the Cesar Bergada Lecture Given during the SLEP 2015 Annual Meeting.
Jasper H
Horm Res Paediatr; 2016; 86(5):291-299. PubMed ID: 27820935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
